{"title":"放射性碘:活生生的历史","authors":"Giuseppe Barbesino, Douglas Ross","doi":"10.1089/ve.2022.0050","DOIUrl":null,"url":null,"abstract":"Dr. Giuseppe Barbesino interviews Dr. Douglas Ross regarding the invited Centennial paper: “Radioactive Iodine: A Living History”, which was coauthored by Dr. Douglas Ross and Dr. Gilbert Daniels. They discuss the period from 1936 to present, focusing on the early development of radioiodine for use in clinical disease. The use of radioiodine has decreased in recent years, and the reasons for this, and what the future may hold, are also discussed. The authors have no relevant disclosures. Runtime of video: 5 mins","PeriodicalId":75302,"journal":{"name":"VideoEndocrinology","volume":"72 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Radioactive Iodine: A Living History\",\"authors\":\"Giuseppe Barbesino, Douglas Ross\",\"doi\":\"10.1089/ve.2022.0050\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dr. Giuseppe Barbesino interviews Dr. Douglas Ross regarding the invited Centennial paper: “Radioactive Iodine: A Living History”, which was coauthored by Dr. Douglas Ross and Dr. Gilbert Daniels. They discuss the period from 1936 to present, focusing on the early development of radioiodine for use in clinical disease. The use of radioiodine has decreased in recent years, and the reasons for this, and what the future may hold, are also discussed. The authors have no relevant disclosures. Runtime of video: 5 mins\",\"PeriodicalId\":75302,\"journal\":{\"name\":\"VideoEndocrinology\",\"volume\":\"72 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"VideoEndocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1089/ve.2022.0050\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"VideoEndocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/ve.2022.0050","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Dr. Giuseppe Barbesino interviews Dr. Douglas Ross regarding the invited Centennial paper: “Radioactive Iodine: A Living History”, which was coauthored by Dr. Douglas Ross and Dr. Gilbert Daniels. They discuss the period from 1936 to present, focusing on the early development of radioiodine for use in clinical disease. The use of radioiodine has decreased in recent years, and the reasons for this, and what the future may hold, are also discussed. The authors have no relevant disclosures. Runtime of video: 5 mins
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
